4.8 Article

Clinical Significance of MPO-ANCA in Eosinophilic Granulomatosis With Polyangiitis: Experience From a Longitudinal Chinese Cohort

Related references

Note: Only part of the references are listed.
Article Rheumatology

2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis

Joanna C. Robson et al.

Summary: The study aimed to develop and validate revised classification criteria for granulomatosis with polyangiitis (GPA). Through consensus methodology and data analysis, 10 criteria items were identified and assigned weights for GPA diagnosis. The criteria demonstrated high sensitivity and specificity in the validation set, making them suitable for research purposes.

ANNALS OF THE RHEUMATIC DISEASES (2022)

Article Rheumatology

2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis

Peter C. Grayson et al.

Summary: The revised classification criteria for EGPA demonstrate strong performance characteristics and are validated for use in research.

ANNALS OF THE RHEUMATIC DISEASES (2022)

Article Rheumatology

2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis

Ravi Suppiah et al.

Summary: The study developed and validated classification criteria for microscopic polyangiitis (MPA), with 6 key items identified for disease classification. Validation results showed high sensitivity (91%) and specificity (94%) for the criteria, confirming their usefulness in clinical research.

ANNALS OF THE RHEUMATIC DISEASES (2022)

Article Rheumatology

Renal involvement in eosinophilic granulomatosis with polyangiitis (EGPA): a multicentric retrospective study of 63 biopsy-proven cases

Cecile-Audrey Durel et al.

Summary: This study found that necrotizing pauci-immune glomerulonephritis is the most common renal presentation in ANCA-positive EGPA, while ANCA-negative patients tend to have other types of glomerulopathies such as membranous nephropathy. Significant eosinophilic interstitial infiltration was observed in over 50% of cases.

RHEUMATOLOGY (2021)

Article Dermatology

Early add-on administration of mepolizumab and intravenous immunoglobulin effective in treating eosinophilic granulomatosis with polyangiitis

Takaharu Ikeda et al.

Summary: Current treatments for EGPA may not always be effective, but early adjunct use of mepolizumab and IVIG could be beneficial for improving symptoms and preventing disease relapse.

JOURNAL OF DERMATOLOGY (2021)

Article Rheumatology

Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss)

Matthias Papo et al.

Summary: PR3-ANCA EGPA patients differ from MPO-ANCA and ANCA-negative patients in clinical presentation, but share similarities with granulomatosis with polyangiitis, suggesting it may be a distinct form of PR3-ANCA-associated vasculitis.

RHEUMATOLOGY (2021)

Article Pharmacology & Pharmacy

Cardiac manifestations of eosinophilic granulomatosis with polyangiitis from a single-center cohort in China: clinical features and associated factors

Suying Liu et al.

Summary: In this study of Chinese EGPA patients, it was found that 36.4% had cardiac manifestations, primarily myocardial involvement, pericardial effusion, and heart failure, which were independently associated with eosinophil count. Treatment with glucocorticoid combined with cyclophosphamide was identified as the cornerstone for managing cardiac manifestations in EGPA patients.

THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2021)

Article Medicine, General & Internal

Trend and Geographic Disparities in the Mortality Rates of Primary Systemic Vasculitis in the United States from 1999 to 2019: A Population-Based Study

Alicia Rodriguez-Pla et al.

Summary: This study analyzed the mortality rates of vasculitis in the United States from 1999 to 2019, finding a decreasing trend in age-adjusted mortality rates. Mortality rates were higher in females than males, with higher rates in White patients, and there were geographic disparities with higher rates in northern states and areas with lower populations.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Critical Care Medicine

International Consensus on Antineutrophil Cytoplasm Antibodies Testing in Eosinophilic Granulomatosis with Polyangiitis

Sergey Moiseev et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

Review Immunology

High-Dose Intravenous Immunoglobulin in Skin Autoimmune Disease

Jochen H. O. Hoffmann et al.

FRONTIERS IN IMMUNOLOGY (2019)

Review Rheumatology

Anti-neutrophil cytoplasmic antibodies and their clinical significance

Supaporn Suwanchote et al.

CLINICAL RHEUMATOLOGY (2018)

Review Critical Care Medicine

Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss)

Yann Nguyen et al.

SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2018)

Review Cardiac & Cardiovascular Systems

Kawasaki Disease

Jane W. Newburger et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)

Article Allergy

High-dose intravenous immunoglobulin therapy for eosinophilic granulomatosis with polyangiitis

Naomi Tsurikisawa et al.

CLINICAL AND TRANSLATIONAL ALLERGY (2014)

Article Rheumatology

2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

J. C. Jennette et al.

ARTHRITIS AND RHEUMATISM (2013)

Review Immunology

Intravenous immunoglobulin therapy: how does IgG modulate the immune system?

Inessa Schwab et al.

NATURE REVIEWS IMMUNOLOGY (2013)

Article Medicine, General & Internal

Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome

G Sablé-Fourtassou et al.

ANNALS OF INTERNAL MEDICINE (2005)